Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 1
2006 1
2007 1
2008 2
2010 2
2011 2
2012 2
2013 3
2014 1
2015 1
2016 1
2017 1
2019 2
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
NGcGM3/VSSP vaccine as treatment for melanoma patients.
Pérez K, Osorio M, Hernández J, Carr A, Fernández LE. Pérez K, et al. Among authors: carr a. Hum Vaccin Immunother. 2013 Jun;9(6):1237-40. doi: 10.4161/hv.24115. Epub 2013 Feb 26. Hum Vaccin Immunother. 2013. PMID: 23442598 Free PMC article. Review.
Marine Seagrass Extract of Thalassia testudinum Suppresses Colorectal Tumor Growth, Motility and Angiogenesis by Autophagic Stress and Immunogenic Cell Death Pathways.
Hernández-Balmaseda I, Guerra IR, Declerck K, Herrera Isidrón JA, Pérez-Novo C, Van Camp G, De Wever O, González K, Labrada M, Carr A, Dantas-Cassali G, Dos Reis DC, Delgado-Roche L, Nuñez RR, Delgado-Hernández R, Fernández MD, Paz-Lopes MT, Vanden Berghe W. Hernández-Balmaseda I, et al. Among authors: carr a. Mar Drugs. 2021 Jan 22;19(2):52. doi: 10.3390/md19020052. Mar Drugs. 2021. PMID: 33499163 Free PMC article.
Safety and Therapeutic Profile of a GnRH-Based Vaccine Candidate Directed to Prostate Cancer. A 10-Year Follow-Up of Patients Vaccinated With Heberprovac.
Junco JA, Rodríguez R, Fuentes F, Baladrón I, Castro MD, Calzada L, Valenzuela C, Bover E, Pimentel E, Basulto R, Arteaga N, Cid-Arregui A, Sariol F, González L, Porres-Fong L, Medina M, Rodríguez A, Garay AH, Reyes O, López M, de Quesada L, Alvarez A, Martínez C, Marrero M, Molero G, Guerra A, Rosales P, Capote C, Acosta S, Vela I, Arzuaga L, Campal A, Ruiz E, Rubio E, Cedeño P, Sánchez MC, Cardoso P, Morán R, Fernández Y, Campos M, Touduri H, Bacardi D, Feria I, Ramirez A, Cosme K, Saura PL, Quintana M, Muzio V, Bringas R, Ayala M, Mendoza M, Fernández LE, Carr A, Herrera L, Guillén G. Junco JA, et al. Among authors: carr a. Front Oncol. 2019 Feb 25;9:49. doi: 10.3389/fonc.2019.00049. eCollection 2019. Front Oncol. 2019. PMID: 30859088 Free PMC article.
Nimotuzumab Site-Specifically Labeled with 89Zr and 225Ac Using SpyTag/SpyCatcher for PET Imaging and Alpha Particle Radioimmunotherapy of Epidermal Growth Factor Receptor Positive Cancers.
Solomon VR, Barreto K, Bernhard W, Alizadeh E, Causey P, Perron R, Gendron D, Alam MK, Carr A, Geyer CR, Fonge H. Solomon VR, et al. Among authors: carr a. Cancers (Basel). 2020 Nov 20;12(11):3449. doi: 10.3390/cancers12113449. Cancers (Basel). 2020. PMID: 33233524 Free PMC article.
Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: results of a Phase Ib/IIa study.
Osorio M, Gracia E, Rodríguez E, Saurez G, Arango Mdel C, Noris E, Torriella A, Joan A, Gómez E, Anasagasti L, González JL, Melgares Mde L, Torres I, González J, Alonso D, Rengifo E, Carr A, Pérez R, Fernández LE. Osorio M, et al. Among authors: carr a. Cancer Biol Ther. 2008 Apr;7(4):488-95. doi: 10.4161/cbt.7.4.5476. Epub 2007 Jan 2. Cancer Biol Ther. 2008. PMID: 18285705 Clinical Trial.
20 results